Tag: overdose

May 10, 2018

Endonovo Therapeutics Signs Distribution Agreement with Plagens Medical Consultants for its Pain Relief Electroceutical SofPulse

Endonovo Therapeutics (OTCQB: ENDV) a commercial-stage developer of Electroceutical Therapies, today announced a distribution agreement with Plagens Medical Consultants for the...
May 9, 2018

Opiant Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results and Provides Corporate Update

Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today reported financial results for the first quarter...
April 18, 2018

Opiant Pharmaceuticals Awarded Grant of Approximately $7.4 Million from the National Institutes of Health for Development of OPNT003

Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced that it has been awarded a...
April 12, 2018

Innovation and Opportunities in the CBD Therapeutics Market

Kalytera Therapeutics CEO Bob Farrell shares his insight into the growing market for cannabinoid-based pharma products in this interview.
March 8, 2018

Opiant Pharmaceuticals Reports Financial Results for August 1, 2017, Through December 31, 2017

Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, following the recent approval by its Board of Directors...
February 13, 2018

Opiant Pharmaceuticals Announces Development of OPNT003

Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced positive data from a Phase I...
February 8, 2018

How Are Pharma Stocks Affected by Opioid Lawsuits?

Since the news about the lawsuits starting in 2016, Insys share price has dropped 65.56 percent from $28.63 to $9.62,...
January 4, 2018

The Basics of the Graphene Market

An exclusive interview with graphene expert Dr. Khasha Ghaffarzadeh, on what is graphene and its key areas of growth.
December 25, 2017

Pharmaceutical Outlook 2018: M&A Deals Could Increase Drug Development

The Investing News Network takes a look at what could be the landscape for the pharma industry and its investors...
December 7, 2017

CBDs Offer a Solution to the Global Opioid Crisis

The increased education surrounding the benefits of CBDs for opioid addiction creates an opportunity for investors to get on the...